
==== Front
Sci RepSci RepScientific Reports2045-2322Nature Publishing Group UK London 4532510.1038/s41598-019-45325-6ArticleAmelioration of obsessive-compulsive disorder in three mouse models treated with one epigenetic drug: unraveling the underlying mechanism Todorov German 1Mayilvahanan Karthikeyan 2Ashurov David 2Cunha Catarina catarina.cunha@nki.rfmh.org 11 0000 0001 2189 4777grid.250263.0Emotional Brain Institute, Nathan Kline Institute, Orangeburg, NY USA 2 0000 0001 2216 9681grid.36425.36Department of Neurobiology and Behavior, Stony Brook University School of Medicine, Stony Brook, NY USA 19 6 2019 19 6 2019 2019 9 874124 10 2018 5 6 2019 © The Author(s) 2019Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Mental health disorders are manifested in families, yet cannot be fully explained by classical Mendelian genetics. Changes in gene expression via epigenetics present a plausible mechanism. Anxiety often leads to avoidant behaviors which upon repetition may become habitual, maladaptive and resistant to extinction as observed in obsessive compulsive disorders (OCD). Psychophysical models of OCD propose that anxiety (amygdala) and habits (dorsolateral striatum, DLS) may be causally linked. The amygdala activates spiny projection neurons in the DLS. Repetitive amygdala terminal stimulation in the DLS elicits long term OCD-like behavior in mice associated with circuitry changes and gene methylation-mediated decrease in the activity of protein phosphatase 1 (PP1). Treatment of OCD-like grooming behavior in Slitrk5, SAPAP3, and laser-stimulated mice with one dose of RG108 (DNA methyltransferase inhibitor), lead to marked symptom improvement lasting for at least one week as well as complete reversal of anomalous changes in circuitry and PP1 gene methylation.

Subject terms
Obsessive compulsive disorderEpigenetics and behaviourHabituationissue-copyright-statement© The Author(s) 2019
==== Body
Introduction
Mental health disorders repeatedly arise in families and often co-occur in twins, but most cases cannot be explained by classical Mendelian genetics. The current model, which could help solve this conundrum, involves long-term modifications in gene expression that are influenced by environmental factors and sometimes are passed onto the following generations (epigenetics)1. Novel studies propose that modulations in gene expression influenced by environmental factors, are connected to mental health disorders2–14.

Epigenetic mechanisms15,16 are essential for normal development and cell differentiation as a way to generate and maintain different specialized tissue-specific phenotypes based on the same genome17. There is accumulating evidence that epigenetic mechanisms have been re-purposed in the nervous system as regulatory participants in long-term neuronal changes essential for neuroplasticity, learning, long-term memory and related functions18–21. DNA methylation is a key epigenetic mechanism that most commonly involves covalent modification of DNA at 5′ position of cytosine (5mC) by the class of enzymes called DNA methyltransferases (DNMT), which could induce long-term gene expression changes (usually silencing but occasionally activation, depending on the region) by preventing RNA-polymerase and transcription factor binding. In mammals, 5mC is highly prevalent and occurs most commonly but not exclusively in CpG pairs22,23.

Non-CpG methylations (CpA, CpT and CpC) also occur but appear to be largely restricted to a few specific cell types, notably neurons and glial cells22,24,25.

There is also evidence of DNA methylation at N6 position of adenine in both prokaryotes and eukaryotes26. However, in mammals, the levels of N6-adenine DNA methylation appear to be very low, except during embryogenesis26, and its physiological role is poorly understood27. N6-adenine DNA methylation does not appear to have any proven regulatory role in the adult mammalian cells28,29. The mammalian enzymes responsible for N6-adenine DNA methylation have not been conclusively identified.

DNMTs are generally expressed and active during development, cell division, and differentiation. They play a major role in setting transcriptional patterns for the differentiated phenotype, which then remain stable over the lifespan of cells. It was believed that once a methylation pattern is set by DNMTs, it remained static in differentiated cells. However, mammalian adult nervous system has comparatively high DNMT activity30,31. The DNMT enzyme family has a number of subtypes that appear to be functionally different. In mammals, subtypes include DNMT1, DNMT2 (a.k.a. TRDMT1), DNMT3A and DNMT3B. In terminally differentiated neurons in adult brains, DNMT1, DNMT3A and DNMT3B appear to be active and possibly dynamically regulated. Studies show that DNMT activity is necessary for long-term memory formation and that DNMT inhibition disrupts long-term memory21. DNMT3A appears to be the specific subtype required for normal de novo learning and memory. Forebrain specific DNMT3A knockout mice, but not DNMT1 knockout mice, exhibited altered LTP and synaptic plasticity in the affected areas as well as learning and memory deficits32. On the other hand, it appears that both DNMT1 and DNMT3A are required for maintenance of methylation and synaptic function as indicated by double-knockout studies33.

In our study we focused on obsessive compulsive disorders (OCD). To assess the role of DNA methylation in OCD-like behaviors, we used two genetic mouse models of OCD-like grooming behavior: SAPAP3 and Slitrk5 knockout (KO) mice34,35. Both SAPAP3 and Sltirk5 KO mice, which exhibit a high degree of OCD-like grooming behavior and anxiety-like behaviors, are considered relevant models for the corresponding human conditions, such as OCD. In fact, mutations in Sltirk5 and SAPAP3 have been linked to increased risk of OCD in humans36,37.

SAPAP3 KO mice lack one of SAP90/PSD-95-associated proteins (SAPAPs, also known as guanilate cyclase associated proteins), a family of scaffold proteins in postsynaptic density34. The net effect of deleting SAPAP3 appears to be the reduction of the sensitivity to AMPAR-mediated glutamatergic signaling.

Slitrk5 KO mice lack a member of the Slitrk family encoding type 1 transmembrane proteins that localize at neuronal synapses and mediate synaptic formation and function through trans-synaptic interactions with presynaptic binding partners. Of the Slitr family, Slitr5 is particularly specific to striatum. The net effect of deleting Slitrk5 in striatum appears to be the reduction in sensitivity to neurotrophic signaling38.

Our third OCD mouse model uses optogenetic laser neuromodulation and is based on psychophysiological model of OCD-like behaviors, which proposes that anxiety (mediated by the amygdala) and habits (managed primarily by dorsolateral striatum or DLS) may be causally linked39. The DLS is composed of two types of spiny projection neurons (SPNs) that project to different targets, receive different excitatory inputs and respond differently to neuromodulators. The so-called indirect pathway SPNs (iSPNs) express D2 type dopamine receptors and ultimately suppress movement by inhibiting thalamic output, while D1 receptor expressing direct pathway neurons (dSPNs) promote it. We have recently shown that the basal and lateral nuclei of the amygdala (BLA) send functional projections directly to SPNs in the DLS, and that these projections target D1s and D2s similarly in wild type (WT) mice40. Furthermore, repeated activation of the BLA-DLS pathway promoted the generation of long-lasting OCD-like grooming behavior41. We treated the OCD-like behavior in the 3 mice models, by subcutaneously injecting a single dose of an epigenetic drug RG108, a non-nucleoside DNA methyltransferase (DNMT) inhibitor. The drug effectively reduced OCD-like behavior in all 3 mice models. In the WT laser-stimulated mice we showed that drug application before laser stimulation prevented the induction of OCD-like behavior. Open field and elevated plus maze test showed that anxiety levels were similar to unstimulated WT mice. We found that circuitry alterations in the RG108 treated mice were back to baseline levels comparable to non-stimulated WT mice. Using qPCR, we examined the role of DNMT methylation in memory, and looked for direct evidence of altered DNA methylation. Protein phosphatase 1 (PP1) is a memory formation inhibitor, and PP1 gene methylation was shown to regulate its expression and activity21,42. We observed a marked increase in methylation level of PP1 gene in the laser-stimulated left hemisphere compared to the unstimulated right hemisphere of the DLS. The increase in PP1 methylation was completely reversed by RG108 injection. These results support the hypothesis that mental health disorders may arise, at least in some cases, from epigenetic modulations leading to impairments of cellular plasticity cascades, which induce aberrant information processing in the circuits. Future disorder-specific, effective and potentially curative therapies would require inducing targeted neuronal plasticity changes to help restore appropriate synaptic function and neuronal connectivity. This study may have implications not only for OCD but also for a variety of complex disorders such as Parkinson’s, schizophrenia, autism, anxiety, and addiction, where the circuits overlapping or resembling the ones we studied have been implicated43.

Results
Epigenetic modulator drugs reduce OCD-like behavior in two different genetic mouse models of OCD
We injected subcutaneously a single dose of RG108, a non-nucleoside DNA methyltransferase (DNMT) inhibitor, in two different genetic mouse models of OCD-like over grooming behavior Slitrk5-deficient and SAPAP3-deficient mice34,35, which reduced this behavior significantly (p < 0.05, Fig. 1a). In Slitrk5-deficient mice the effect of the drug was long-lasting and led to reduction of over-grooming-inflicted lesions, while in the SAPAP3-deficient mice the effect only persisted for 3 days (Fig. 1a). SAPAP3-deficient mice seem to represent a more persistent case of OCD-like grooming behavior partially resistant to long lasting epigenetic modulatory effects of RG108. In the next set of experiments, we administered subcutaneously sodium butyrate (NaB), which inhibits class I histone deacetylase (HDAC) activity, inducing histone hyper-acetylation,44,45, and was shown to strengthen cocaine-associated contextual memory46. We observed that in the SAPAP3-deficient and Slitrk5-deficient mice the OCD-like grooming behavior was increased in all mice (p < 0.05). A single injection of RG108 reduced the OCD-like grooming behavior immediately in all mice and was long lasting (at least 7 days) in Slitrk5-deficient mice (p < 0.05, Fig. 1b).Figure 1 RG108 effectively reduced and prevented maladaptive habitual avoidance-like behavior in two different genetic mouse models. (a) Single subcutaneous injection of RG108 into Slitrk5 KO (more than 7 days) and SAPAP3 KO (3 days) mice reduced habitual grooming behavior. N = 5–6; p < 0.05 KO saline group is a mix of both KOs (N = 4 and N = 4). (b) Single subcutaneous injection of sodium butyrate (NAB) into Slitrk5 KO and SAPAP3 KO mice increased habitual grooming behavior. N = 5–6; p < 0.05. Injection of RG108 after NAB application reversed the increased habitual grooming behavior. N = 5–6; p < 0.05.



PP1 gene methylation levels are proportionate to OCD-like behavior levels in KO mice
To gain a deeper insight into the role of RG108 in OCD-like behavior, we tested for direct evidence of altered DNA methylation related to memory. Studies of contextual fear conditioning and novel object recognition suggest that protein phosphatase 1 (PP1) is a memory suppressor gene21,42. The inhibition of PP1 activity enhances LTP, the efficacy of associative training, and the maintenance of memory42,47,48. Analysis of PP1 expression patterns in the mammalian brain demonstrates that PP1 is most abundantly expressed in the striatum49 and that PP1 expression and activity are regulated by its methylation state21,42. We performed methylation-specific quantitative real-time PCR to examine methylation changes in the DLS of the specific target gene PP1 in the different mouse models of OCD with and without drug application. We detected the levels of methylated PP1 of 5.2 log-2-fold-change in untreated KO mice relative to WT controls (p < 0.01, Fig. 2). Treatment with RG108 reduced the level of methylated PP1 to an undetectable level while the level of un-methylated PP1 increased to an over 4.02 log-2-fold-change (p < 0.01, Fig. 2). NaB injection downregulated the level of un-methylated PP1, resulting in −5.5 log-2-fold-change, and increased the level of methylated PP1, leading to an 13.86 log-2-fold-change (p < 0.01, Fig. 2).Figure 2 PP1 gene methylation in KO mice. PP1 methylated and un-methylated levels (comparison to WT mice) of untreated vs RG108 and NAB treated KO mice. N = 4. p < 0.05.



Considering both the behavior and gene methylation results, we concluded, that our BLA-DLS pathway laser-stimulated WT mice might represent a valid and useful mouse model for OCD-like behavior. Additionally, this mouse model allowed us to control neuromodulation precisely (time point, duration, localization, intensity, and frequency), which would enable us to gain deeper insights into underlying mechanisms of OCD-like behavior. Therefore, we wanted to study further which underlying mechanisms took place in laser-stimulated WT mice showing OCD-like behavior. The inhibitory mechanism of RG108 appears to be direct and specific, and it shows comparatively low toxicity in human cancer cell lines50. This makes RG108 is an interesting candidate for further studies as a potential therapeutic agent. Therefore, we will focus our next experiments on RG108.

Epigenetic modulator RG108 reduces OCD-like behavior in optogenetic laser neuromodulation mouse model of OCD
Our third mouse model for OCD-like behavior is based on optogenetic laser neuromodulation (Fig. 3).Figure 3 In vivo optogenetic activation of BLA inputs to the dorsolateral striatum. (a) Injection of AAV-synapsin-ChR2-GFP construct into the basal and lateral amygdala (BLA). Placement of fiberoptic cannulas and blue laser stimulation in DLS. The dorsolateral striatum was stimulated by a blue laser coupled to an implanted cannula for 10 minutes a day, over 5 days, in mice receiving AAV-ChR2 or saline injections into the BLA. (b) Example injection site of AAV-synapsin-ChR2-GFP construct into the BLA. c Example placement of fiberoptic cannula in DLS.



The previously described knock out mice present a genetic mouse model of OCD. However, most cases of mental health disorders cannot be fully explained by classical Mendelian genetics. Based on that knowledge, we wanted to study which brain circuitry modulations could represent an underlying or contributing mechanism for OCD. Psychophysical models of OCD propose that anxiety (represented by the amygdala) and habits (involvement of the DLS) may be causally linked39. We recently showed that the BLA sends functional projections directly to striatal spiny projection neurons (SPNs) in the dorsolateral striatum (DLS), and that these projections target direct pathway SPNs (D1s) and indirect pathway SPNs (D2s) similarly in WT mice40. Repeated optogenetic in vivo stimulation of BLA axon terminals in the DLS gradually induced long lasting OCD-like grooming behavior in WT mice (p < 0.05, Fig. 4a). We injected one dose of RG108, into the laser-stimulated mice which lead to a reversal of OCD-like grooming behavior lasting for at least one week (p < 0.05, Fig. 4a). In order to study if RG108 was able to prevent OCD-like grooming behavior, we injected the drug 10 min before each laser stimulation session, which confirmed our hypothesis (p < 0.05, Fig. 4b).Figure 4 RG108 effectively reduced and prevented OCD-like (over grooming) behavior in laser stimulated WT mice. (a) Unilateral stimulation of the BLA input in the dorsolateral striatum with a blue laser coupled to an implanted cannula for 10 minutes a day, over 5 days, in mice receiving RG108 or saline injections 10 min before laser stimulation. The second control group had implanted sham cannulas, so the laser stimulation didn’t show an effect on grooming behavior. Behavior was measured for 5 min before daily laser stimulation, as well as 3 and 7 days after last stimulation. N = 5–7; p < 0.05. (b) The dorsolateral striatum was stimulated by a blue laser coupled to an implanted cannula for 10 minutes a day, over 5 days, in mice. After 3 days of the last laser stimulation the mice received RG108 or saline injections. Behavior was measured for 5 min before daily laser stimulation. Unilateral activation of BLA inputs increased OCD-like behavior (over grooming). After RG108 injection the OCD-like behavior was reduced. Saline injections didn’t have this effect. N = 5–7; p < 0.05.



PP1 gene methylation levels are proportionate to modulated OCD-like behavior levels in laser-stimulated WT mice
We studied PP1 methylation state (levels of methylated and un-methylated forms of PP1) in the optogenetic laser neuromodulation (unilateral left hemisphere) mouse model of OCD with and without drug application in the DLS. We found the levels of un-methylated PP1 to be higher in the right hemisphere DLS (3.8 log-2-fold-change) than in the stimulated left hemisphere DLS (1.8 log-2-fold-change, p < 0.01, Fig. 5). The opposite was detected for the methylated PP1 levels, where the right hemisphere showed low levels of a 1.2 log-2-fold-change and the left hemisphere had high levels of 8.7 log-2-fold-change (p < 0.01, Fig. 5). A single injection of RG108 significantly downregulated methylated PP1 levels to negative values (below control baseline) in both hemispheres, with −3.5 and −3.7 log-2-fold-change in the right and left DLS correspondingly (p < 0.01, Fig. 5).Figure 5 PP1 gene methylation in WT mice. Comparison (to WT unstimulated) of PP1 methylated and un-methylated levels of WT unilateral (left hemisphere) laser stimulated untreated mice and RG108 treated right vs left hemisphere. N = 4 p < 0.05.



RG108 modulates anxiety-like behavior
Laser-stimulated WT mice spent significantly less time in the center of the open field than sham cannula mice (p < 0.05). Laser-stimulated mice that were injected with a single dose of RG108 spent as much time in the center of the open field as the sham cannula mice. Elevated plus maze tests showed that untreated laser-stimulated WT mice spend the least time in open arms compared to RG108 treated laser-stimulated WT mice and laser-stimulated WT mice implanted with sham cannulas (Fig. 6a,b, p < 0.05).Figure 6 RG108 reduced anxiety-like behavior. (a) Time spent in the center of open field was significantly different between laser stimulated and sham cannula mice. RG108 injection increased the time spent in the open field of laser-stimulated mice. N = 5; p < 0.05. (b) The mobility measured by distance traveled during the open field test is not different between groups. N = 5; p > 0.05. (c) RG108 injected mice showed similar behavior in the elevated plus maze as the control mice. N = 5; p < 0.05.



Circuitry alterations induced by laser stimulation of the BLA-DLS pathway were reversed in RG108 treated mice, and comparable to non-stimulated WT mice
In order to measure paired pulse ratios (PPR), we used acute coronal brain slices where we stimulated with 2 laser pulses (1 μm radius) the same spot using a 100 ms interval, the BLA input onto the SPNs in the DLS 400 um away from recorded neurons. We observed paired pulse depression (PPD) in the BLA input to the SPNs of the DLS in WT mice. In brain slices from in vivo laser-stimulated WT mice showing OCD-like behavior, we recorded a reduction in PPRs in D1s of the DLS (Fig. 7a,b, p < 0.05). Injection of RG108 reversed this effect in the D1s (Fig. 7a,b, p < 0.05).Figure 7 Circuitry alterations of the RG108 treated mice were back to baseline levels comparable to non-stimulated WT mice. (a) PPR evaluated at 100-millisecond (msec) intervals. The PPR values were computed as the ratio of the second stimulus-evoked EPSC peak divided by the first stimulus-evoked EPSC peak. The PPRs of WT and laser stimulated WT DLS slices (WT saline: D1 N = 8, D2 N = 7; WT laser stimulated: D1 N = 8, D2 N = 7, RG108 injected D1 N = 8, D2 N = 9) were calculated from the averaged PPR values. p < 0.05. (b) Example traces of D1 recordings under control conditions, after laser stimulation and application of RG108. N = 9 D1s. (c) Relative NMDA/AMPA receptor contribution is elevated at BLA-D1 synapses in laser stimulated mice, and RG108 injection reverses the levels back comparable to controls. EPSCs evoked by full-field optogenetic stimulation in mice receiving stereotaxic ChR2 injections into BLA or sensorimotor cortex; NMDA/AMPA receptor-mediated synaptic contributions measured. N = 9 D1s and N = 9 D2s; p < 0.05. d Example traces of dSPN recordings under control conditions, after laser stimulation and application of RG108. N = 9 D1s.



In order to detect changes in NMDA/AMPA ratios, we recorded in voltage clamped SPNs BLA input laser stimulation evoked AMPA currents at −70 mV, and NMDA currents at +40 mV. D1s in the DLS from laser-stimulated WT mice displaying OCD-like behavior, showed a significant increase in NMDA/AMPA ratios, which was reversed through RG108 treatment (Fig. 7c,d, p < 0.05).

High magnification images (5 × Zoom) of SPN dendrites in the DLS showed a higher spine density in D1s in laser-stimulated mice with OCD-like behavior compared to controls (sham cannula). RG108 reversed this effect and re-established the balance between the direct and indirect pathway (Fig. 8a,b, p < 0.05).Figure 8 Repeated in vivo stimulation of BLA inputs to the dorsolateral striatum increases WT spine density mainly in the D1s and RG108 reverses it. (a) Measurements taken a week after the last stimulation and drug injection. Drug manipulation recapitulates the same spine density seen in unstimulated (sham) WT mice. N = 9–16. p < 0.05. (b) Example dendritic spines under different conditions.



Discussion
Our results show that a single dose of DNMT inhibitor RG108 markedly reduced maladaptive habitual grooming behavior in both SAPAP3 and Sltirk5 KO mice. In Slitrk5 KO mice, grooming decreased to the normal level and remained within the wild type (WT) range for at least 7 days after the treatment. In SAPAP3 KO mice, whose pathological habitual grooming is more severe compared to Slitrk5, over-grooming decreased markedly but was still above the WT range. The behavior improvement in SAPAP3 KO mice lasted between 3 and 7 days’ post-treatment–on day 7 post-treatment, the over grooming was only mildly below the pre-treatment level.

Furthermore, we found that a single dose of HDAC inhibitor sodium butyrate (NaB) markedly increased OCD-like behavior (over-grooming) in both in SAPAP3 and Sltirk5 KO mice, the effect being especially dramatic in SAPAP3 mice. In both KO mouse strains, the over-grooming increase was the greatest 30 minutes after the injection, gradually decreasing over the next few days and still above the original baseline on day 7. The stimulatory effect of HDAC inhibitor NaB on over-grooming in KO mice was completely offset by concurrent administration of DNMT inhibitor RG108, the resultant grooming level dropping below the original baseline. Thus DNMT inhibitor not only partially or completely suppressed pathological OCD-like behavior in KO mice but also overcame the opposing stimulatory effect of HDAC inhibition.

To further verify the role of epigenetic mechanisms in the observed effects and to identify a potential regulatory target we used qPCR to analyze methylation levels of protein phosphatase 1 (PP1) gene in KO mice. PP1 inhibits memory formation and learning42. Since habit formation in OCD-like behavior can be viewed as a variant of the memory/learning mechanism, we presumed PP1 to be among the likely regulators involved. Furthermore, previous studies reported that an increase in PP1 methylation reduced its expression, which lead to a decrease in memory inhibition21.

We found that DNMT inhibition lead to a marked reduction in PP1 methylation in the DLS of the KO mice. Conversely, HDAC inhibition lead to changes in the opposing direction: a marked increase in PP1 methylation and presumably the corresponding reduction in the PP1 expression21.

HDAC is known to enhance memory and synaptic plasticity via CREB:CBP-dependent signally51. Additionally, a recent study reported that suppression of HDAC3 function in DLS accelerates habit formation whereas HDAC3 overexpression prevents it52. HDAC3 is a class I HDAC highly expressed in the brain and believed to be enriched at learning-related and CREB-regulated gene promoters53,54. Conversely, the CREB phosphorylation by PP1 was reported to suppress CREB activity55. In that context, our data on the opposing effects of DNMT and HDAC inhibition on maladaptive habitual behaviors and PP1 activity suggest the opposing effects of DNA demethylation and histone acetylation on CREB:CBP-dependent pathway, which is known to be involved in neuroplasticity56,57. In fact, PP1 and CREB:CBP may represent a key nexus of epigenetic regulation of neuroplasticity occurring during the development and reversal of OCD-like behaviors.

At present, SAPAP3 and Sltirk5 KO mice are arguably the most clinically relevant models of OCD-like behaviors available in rodents. Yet it remains unclear how these genetic lesions lead to the behavioral manifestations, which makes interpreting the effects of epigenetic interventions in the KO mice more difficult. Slitrk5 deletion was shown to reduce the sensitivity to neurotrophic signaling by BDNF35 whereas SAPAP3 deletion appears to reduce the sensitivity to AMPAR-dependent glutamatergic signaling34. A long-term reduction in DLS sensitivity to inputs, whether via BDNF or AMPA pathway, would likely produce compensatory regulatory changes in the DLS and, perhaps more importantly, in the circuits connected to it from BLA, thalamus and cortex. Such compensatory changes may favor inputs via movement stimulating dSPN circuitry over the inhibitory iSPN circuitry, facilitating excessive LTP and more sustained upstates in dSPNs in the DLS, thus lowering the trigger threshold of OCD-like behaviors. This hypothesis is consistent with our findings but requires substantial further investigation to confirm.

Why is the suppression of over-grooming by DNMT inhibition less sustained in SAPAP3 KO mice? SAPAP3 KO mice show much more severe over-grooming than Sltirk5 KO or BLA-DLS laser-stimulated WT mice. This may reflect a far greater level of baseline imbalance between movement activating (D1) and inhibitory (D2) pathway in DLS circuitry. A highly intense and sustained activation is known to cause not only transient synaptic changes but also a longer-term one (LTP, LTD), partly via epigenetic modifications58. Hence it is possible that in the case of SAPAP3 KO mice, epigenetic changes produced by a single dose of DNMT inhibitor are more likely to be reversed over time.

We found that in WT mice DNMT inhibition caused a dramatic, rapid, and sustained improvement in OCD-like behaviors induced by laser stimulation. A single RG108 injection suppressed over-grooming in laser-stimulated mice for at least seven days. A similar improvement was observed in anxiety-like behavior in elevated plus maze. We showed that behavioral changes associated with laser stimulation and RG108 injection correlated with changes in circuitry. Additionally, laser stimulation of BLA-DLS inputs increased the density of D1 dendritic spines and produced changes in D1 & D2 paired pulse and AMPA/NMDA ratios, which correlated with the exacerbation of maladaptive behaviors. DNMT inhibition reversed laser stimulation-induced circuitry changes, such that BLA-DLS inputs resembled (functionally and morphologically) those in unstimulated WT mice. Laser stimulation-induced OCD-like behavior in WT mice was associated with an increase in PP1 gene methylation in the DLS of the left hemisphere (unilateral stimulation) to levels comparable to those in KO mice. Conversely, only mild PP1 methylation changes were observed in the right hemisphere (contralateral side of unilateral stimulation). A single treatment of the laser-stimulated WT mice with DNMT inhibitor RG108 completely reversed PP1 methylation increase in the DLS.

The high degree of alignment between observed behavioral and regulatory effects of epigenetic modulation in both gene knockout and laser stimulation based mouse models point to the key physiological role of epigenetic mechanisms in OCD-like behaviors as well as likely clinical relevance of SAPAP3 and Stilrk5 KO mice as animal models. In fact, the aforementioned decrease in the striatum sensitivity to inputs and the resulting overcompensation/over activity of D1 movement stimulating circuit connections to DLS may not be limited to SAPAP3 and Stilrk5 KO mice. Numerous genetic and environmental factors may reduce striatum sensitivity and lead to maladaptive overcompensation, potentially accounting for a significant proportion of cases of pathological OCD-like behaviors.

Our results show that DNMT inhibition can trigger neuroplasticity and long-term synaptic changes in circuitry involved in OCD-like behaviors. Rapid onset of the behavioral changes we observed after DNMT inhibition indicates that the DNA methylation state of the affected neurons is not static. Inhibition of active methylation is likely to alter DNA methylation patterns (and thus gene expression and behavior) only if there is an active process of demethylation continuously opposing methylation in adult neurons. Since both DNMT and TET enzymes are continuously expressed in adult neurons31,33,59, they likely maintain a certain equilibrium level of methylation (dynamic steady state), which is apparently required in order to maintain the existing synaptic functions. Disrupting this methylation steady state by interfering with either DNMT (methylation) or TET (hydroxymethylation and demethylation) causes the opposing process to prevail, presumably by activating neuroplasticity/synaptic changes via CREB:CBP-dependent pathway. In our experiments, DNMT inhibition lead to rapid onset of behavioral changes presumably due to the decrease in methylation brought about by unopposed activity of TET enzymes. We can speculate that inhibition of DNMT1 and DNMT3A may be particularly important in the observed effects. Further studies targeting either specific DNMTs enzymes (via more specific inhibitors) or the expression of their genes (e.g. using miRNAs) in the context of OCD-like behaviors may help clarify the involvement of specific DNMT subtypes and suggest narrower therapeutic targets.

Prior studies of TET activity in adult neurons suggest that the loss of methylation following DNMT inhibition is likely produced by an increase in hydroxymethylation by TET1 and/or TET3, subtypes shown to be involved in adult neuroplasticity60. Future research involving dynamic overexpression or repression of specific TET enzymes within striatum and related structures should clarify their role and therapeutic potential in obsessive-compulsive behaviors. Considering the potentiating effect of HDAC inhibition on OCD-like behaviors, investigating the effects of HDAC overexpression (especially HDAC3) and HAT inhibition may also yield new therapeutic targets.

Taken together, morphological (spine density), physiological (receptor and paired pulse ratios), and molecular (PP1 gene methylation) changes associated with laser stimulation-induced OCD-like behavior in mice indicate long-term potentiation (LTP) in the BLA-DLS circuitry, specifically affecting D1s. We showed that all of the above changes are either completely reversed or markedly diminished by DNMT inhibition, indicating the sustained reversal of LTP, which could also be viewed as a form of long-term depression (LTD) of D1 BLA-DLS circuitry.

In fact, reduction in spine density is a common characteristic of LTD and involves limited synaptic apoptosis affecting spines61, which can be viewed as a form of synaptic pruning. Synaptic apoptosis/pruning appears to involve limited autophagy triggered via mTOR pathway by direct or indirect mTOR kinase inhibition. Modulation of mTOR pathway via epigenetic mechanisms involving DNA methylation and histone modifications was shown to play a role in memory reconsolidation18. It was found that memory retrieval was associated with transient suppression of mTOR pathway (activation of autophagy) while the subsequent reconsolidation was linked to mTOR pathway activation (suppression of autophagy), both involving epigenetic regulatory changes. These epigenetically mediated fluctuations in synaptic strength observed during memory retrieval and consolidation may have an equivalent in striatal activity involved in obsessive-compulsive behaviors. Activation of habitual motor behaviors is likely to rely on the same neuronal mechanisms as memory retrieval and reconsolidation and may also involve, even in a steady state, frequent epigenetically mediated fluctuation in synaptic strength. This would be consistent with our findings that epigenetic modulators can influence OCD-like behaviors. The role of synaptic apoptosis/pruning and mTOR pathway in OCD-like behavior should be further investigated.

We should note that a single dose of DNMT inhibitor reversed the laser-induced increase in D1 spine density while D2 spine density did not change significantly. Once the synaptic strength of D1 spines is reduced, the inhibitory D2 spines presumably rebalance BLA-DLS circuit leading to suppression of anomalous behavior and perhaps contributing to LTD in D1s.

A similar regulatory interplay of D1 and D2 mediated sub-circuits was found in fear extinction studies, which may point to a generic regulatory/neuroplasticity mechanism across various forms of memory and learning where epigenetic changes play a key regulatory role62.

Our results indicate that both the development and reversal of OCD-like behaviors involve neuroplasticity resulting in circuitry changes in BLA-DLS and possibly elsewhere. Particularly, in laser-stimulated mice we observed long-term potentiation of D1s, whereas in RG108 treated laser-stimulated mice we observed normalization of behavior associated with long-term depression of D1s. The observed LTP and LTD through BLA-DLS pathway modulations appear to involve regulatory epigenetic changes. In that context, DNA methylation changes associated with OCD-like behaviors are likely to engage methyl-CpG-binding protein 2 (MeCP2) as one of the regulatory mediators. MeCP2 is a regulatory factor that binds to common DNA methylation site CpG, which in turn affects the expression of multiple genes63. MeCP2 has essential maintenance role in mature adult neurons and modulates both synaptic development and function. Loss-of-function mutations of MeCP2 cause neurodevelopmental disorder Rett Syndrome in humans and neurological dysfunction in mice characterized by impaired memory/learning and low synaptic density64. The demethylation we induced indirectly by DNMT inhibitor would be expected to have some functional similarities to the loss of MeCP2 as both should counteract the effects of methylation–either via elimination of methyl-CpG sites or via lack of the regulatory factor binding to methyl-CpG, correspondingly. In fact, D1 spine density reduction in DLS that we observed after RG108 administration is consistent with prior findings that the lack of MeCP2 is associated with low synaptic density65. This phenomenon is likely to be partly mediated by mTOR pathway that we discussed earlier. A loss-of-function MeCP2 gene mutation leads to reduction in mTOR pathway activity (greater autophagy) and reduced neuronal size in mice64.

Importantly, MeCP2 appears to modulate the inducibility of some of the immediate early genes (IEG) of synaptic plasticity, which was shown specifically in striatum for junb and Arc63. In that context, the effects of methylation and MeCP2 on Arc expression appear particularly relevant because Arc was shown to be involved in complex regulation of various forms of neuroplasticity, including LTP, LTD and synaptic scaling66,67. Particularly noteworthy are recent studies showing the capability of Arc protein to transport different payloads, such as RNA, between neighboring dendrites and neurons68. Under certain conditions, Arc proteins assemble into carrier particles resembling a viral capsid that can be transported in and out of neurons via endo/exocytosis68. The nature of the cargo, co-factor binding and other insufficiently understood variables apparently determine the Arc’s role in each particular type of plasticity. The inter-neural transport mechanism facilitated by Arc is consistent with Hebbian cooperativity characteristic of both LTP and LTD69. Epigenetic control of Arc-dependent pathways appears to be a promising avenue of future research.

While epigenetic drugs, and methylating/demethylating agents in particular, appear to hold promise for mental health disorders, there is a potential for significant side-effects. In particular, methylation/demethylation may lead to long-term changes in the activity of oncogenes and conceivably to an increase in the rates of cancer. Further research is needed to identify such risks and find ways to mitigate them. It is likely that different methylating/demethylating agents affect methylation patterns somewhat differently and thus carry different levels and types of risks and benefits. Such differences may be due to DNMT or TET enzyme subtype specificity, involvement of different DNMT-inducing complexes, DNA conformation or sequence specificity and other factors. In fact, some DNMT inhibitors appear to produce anti-cancer effects, presumably by reversing the silencing of tumor suppressor genes70,71. Other approaches to reducing the side-effects of epigenetic drugs could include reducing the effective dosage by combining them with relevant non-epigenetic drugs or targeting only specific tissues. For example, the effective dosage of the epigenetic drugs in treating disorders associated with abnormal neuroplasticity, such as OCD or phobias, might be lowered by concurrently administering non-epigenetic neuroplasticity enhancing agents, such as edonerpic maleate72. Also, when treating neurological or psychiatric conditions with epigenetic drugs, it should be feasible to preferentially target the nervous system by leveraging the properties of the blood-brain barrier. For example, a small molecule drug, such as RG108, that crosses the blood brain barrier (BBB) may be co-administered with a neutralizing agents, such as an antibody, that does not cross the BBB, potentially leading to effective concentrations only in the CNS. Alternatively, an epigenetic drug that does not cross the BBB could be administered intrathecally, reaching effective concentrations only in the CNS73.

This study has demonstrated the involvement of epigenetic mechanism in the behavioral and circuitry changes associated with the development and reversal of maladaptive habitual behaviors. We focused on the BLA input to the DLS. The BLA modulates the DLS activity via the two opposing pathways of movement stimulation (D1) and movement inhibition (D2), whose anomalies we showed to be associated with OCD-like behaviors. However, similar regulatory circuits and mechanisms appear to be involved in many other brain structures and functions where epigenetic interventions may also have therapeutic potential. Hence better understanding of these mechanisms may lead to new treatments not only for obsessive-compulsive disorder but also many other pathologies characterized by aberrant synaptic plasticity and circuitry dysregulation persisting due to epigenetic changes

Methods
Animals
We used 3–6 month old male and female Slitrk5 and SAPAP3 KO mice34,35. SAPAP3 mice were used at 3–4 months of age (when they are symptomatic). Because Slitrk5 mice display a protracted disease progression when crossed onto a C57BL/6-SV129 background, they were used at 5–6 months. We used 3–6 month old male and female mice for the WT laser-stimulated mouse model, hemizygously expressing either drd1-tdTomato or drd2-eGFP74,75. All mice were housed individually in home cages with 12 h light/dark cycle with food and water ad libitum. All animals in all groups received the same treatment (except for the active agent being investigated, such as an epigenetic drug or laser stimulation). The control and experimental groups underwent the same procedures. The research complied with the National Institutes of Health Guide for Care and Use of Laboratory Animals, and was approved by the Animal Welfare Committee of our institute, NY, USA.

Surgeries
For stereotaxic surgery, rats were anesthetized with ketamine and xylazine and secured in a Leica Biosystems stereotaxic apparatus. WT mice received unilateral injections of synapsin-ChR2-GFP-AAV76 construct (UPenn vector core) at 2–5 months of age. Stereotaxic injections targeted the BLA (ML −2.99, AP −1.22, DV −4.38). In the same surgery, a mono fiber optic cannula (core diameter 200 μm, outer diameter 245 μm, 0.37 NA, Doric Lenses) was implanted in the dorsolateral striatum (0.6 mm anterior to Bregma, tip depth 2.7 mm below pia surface) and held in place with dental cement. After the implantation surgery, animals were allowed to recover for 5 to 7 days.

Behavior
Two weeks following surgery, cannula were magnetically coupled to a fiber optic patch cord attached to a 473 nm blue LASER, and placed in a clear Plexiglas cylinder (13 cm diameter). Mice were acclimated to this configuration for 3 days, 20 minutes per day. After acclimation and baseline measurements, the dorsolateral striatum was stimulated by the LASER using 10 ms pulses (3 mW) at 10 Hz for 10 minutes, once daily for 5 days,  based upon previous studies77. Control mice received saline injections or sham cannula implants. Mice were videotaped in the Plexiglas cylinder to assess grooming during 3 epochs: (i) 5 minutes before laser stimulation, (ii) during laser stimulation, and (iii) 5 minutes after laser stimulation. Grooming was also assessed for 3 days before the first stimulation, and 1 week following the last LASER stimulation. Total time spent grooming, number and duration of grooming bouts, and body region groomed (head, core or tail) was quantified by observers blind to experimental conditions.

Open field behavior and performance in an elevated plus maze were tested after the stimulation protocol as general measures of locomotion and anxiety-like behavior78,79, and analyzed with EthioVision XT software. Data from drd1-tdTomato and drd2-eGFP mice were pooled for behavioral analysis.

Electrophysiology
The mice were anesthetized with a mixture of ketamine (50 mg/kg) and xylazine (4.5 mg/kg) and perfused transcardially with 5–10 ml ice-cold artificial CSF (ACSF) containing (in mM): 124 NaCl, 3 KCl, 1 CaCl2, 1.5 MgCl2, 26 NaHCO3, 1 NaH2PO4, and 16.66 glucose, continuously bubbled with carbogen (95% O2 and 5% CO2). The slices were then transferred to a holding chamber where they were incubated in ACSF containing (in mM) 2 CaCl2, 1 MgCl2, at 35 °C for 60 min, after which they were stored at room temperature until recording. Identified SPNs were recorded from on a multi-photon system equipped with integrated electrophysiological capabilities. The recording electrode contained (in mM) for current-clamp recording: 135 K-gluconate, 7 KCl, 10 HEPES, 10 Na-phosphocreatine, 4 Mg2-ATP, and 0.4 Na-GTP (290–295 mOsm, pH 7.35 with KOH). Voltage-clamp recordings used (in mM): 135 Cs-gluconate, 10 HEPES, 10 Naphosphocreatine, 4 Mg2-ATP, and 0.4 Na-GTP (290–295 mOsm, pH 7.35 with CsOH) and red fluorescent anatomical dye Alexa 568 (50 μM) (Invitrogen). ChR2 stimulation of BLA terminals in the DLS were evoked by stimulating the DLS with two laser pulses 400 μm away from the neurons. Excitatory postsynaptic currents (EPSCs) were recorded from a projection neuron in the DLS in response to optogenetic paired-pulse stimulation (1 ms) with an interval of 100 ms. The averaged paired-pulse ratio of the amplitudes (PPR = EPSC2/EPSC1) were calculated after recording.

In order to detect changes in NMDA/AMPA ratios, we recorded in voltage clamped SPNs BLA input laser stimulation evoked AMPA currents at −70 mV, and NMDA currents at +40 mV80,81.

For spine density studies, high magnification z-series images (0.2 μm steps, 5x digital zoom) were taken through two distal (>100 μm from soma) and proximal (60 μm from soma) dendritic areas. The distance from soma was measured by a straight line drawn from the site of stimulation to the origin of the dendrite at the soma. The images were de-convoluted using AutoQuant X2 (Media Cybernetics) and for spine density analysis we used neuron studio6482.

Low magnification z-series images (1 μm steps, 1x digital zoom) were taken through the depth of the entire recorded neuron.

Drugs
RG108 (Sigma) was dissolved in 10% DMSO and sterile saline and injected subcutaneously at 0.8 mg/kg dosage. Sodium butyrate (NaB, Sigma) was dissolved in sterile saline and injected subcutaneously at 1.2 mg/kg dosage.

DNA Methylation Assay
This DNA methylation assay was performed as published by21. Detection of un-methylated PP1 DNA was performed using the following primer21: Forward (5′-GAGGAGAGTTTGGTGTTTATAAGATGGT-3′) and reverse (5′-TCCTCCAAAAACTCAACTCAAACAA-3′). Detection of methylated PP1 DNA was performed using the following primer21: Forward (5′-GGAGAGTTTGGTGTTTATAAGATGGC-3′) and reverse (5′-CGAA AACTCGACTCGAA CGA-3′). PCRs were performed in a StepOnePlus real-time PCR system (ThermoFisher). To further verify specificity of the final product, 5 μl of the amplified products were analyzed by electrophoresis on a 2% agarose gel stained with ethidium bromide and visualized under UV light. Quantitative PCR was run three times with each sample. For every quantitative PCR, samples were assayed in triplicate and the Ct value for each sample was chosen in the linear range. Samples were normalized to a control unstimulated and untreated WT sample, and the comparative Ct method was used to calculate differences in gene expression between samples (log-2-fold-change).

Statistical analysis
All data were presented as the mean ± standard error. All statistics were performed using GraphPad Prism 5.0b. Comparison between two groups was evaluated by an unpaired Student’s t-test. Differences between treatment groups were evaluated using one-way or two-way ANOVA with Tukey post hoc comparison tests. Statistical significance was defined as p < 0.05.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author Contributions
German Todorov and Catarina Cunha conceived of the presented idea. Catarina Cunha developed the experimental design, performed experiments and oversaw the project. German Todorov analyzed and verified the data and analytical methods. Karthikeyan Mayilvahanan and David Ashurov assisted Catarina Cunha with the blind analysis of behavior data. All authors discussed the results and contributed to the final manuscript.

Data Availability
The data that support the findings of this study are available from the corresponding author (C.C.), upon reasonable request.

Competing Interests
The authors declare no competing interests.
==== Refs
References
1. Waddington CH   The epigenotype. 1942 Int J Epidemiol 2012 41 10 13 10.1093/ije/dyr184 22186258 
2. Egger G  Liang G  Aparicio A  Jones PA   Epigenetics in human disease and prospects for epigenetic therapy Nature 2004 429 457 463 10.1038/nature02625 15164071 
3. Heindel JJ  McAllister KA  Worth L Jr.  Tyson FL   Environmental epigenomics, imprinting and disease susceptibility Epigenetics 2006 1 1 6 10.4161/epi.1.1.2642 17998808 
4. Jirtle RL  Skinner MK   Environmental epigenomics and disease susceptibility Nat Rev Genet 2007 8 253 262 10.1038/nrg2045 17363974 
5. Lobanenkov V  Loukinov D  Pugacheva E   Environmental epigenomics and disease susceptibility. Keystone symposia on molecular and cellular biology. The Grove Park Hotel & Spa, Ashville, NC, USA, 27 March-1 April 2011 Epigenomics 2011 3 261 266 10.2217/epi.11.25 22122336 
6. Ozanne SE  Constancia M   Mechanisms of disease: the developmental origins of disease and the role of the epigenotype Nat Clin Pract Endocrinol Metab 2007 3 539 546 10.1038/ncpendmet0531 17581623 
7. Sheerin CM  Lind MJ  Bountress KE  Nugent NR  Amstadter AB   The genetics and epigenetics of PTSD: overview, recent advances, and future directions Curr Opin Psychol 2017 14 5 11 10.1016/j.copsyc.2016.09.003 28813320 
8. Skinner MK   Environmental epigenomics and disease susceptibility EMBO Rep 2011 12 620 622 10.1038/embor.2011.125 21681201 
9. Whitelaw NC  Whitelaw E   How lifetimes shape epigenotype within and across generations Hum Mol Genet 15 Spec No 2006 2 R131 137 10.1093/hmg/ddl200 
10. Heijmans BT    Persistent epigenetic differences associated with prenatal exposure to famine in humans Proc Natl Acad Sci USA 2008 105 17046 17049 10.1073/pnas.0806560105 18955703 
11. Painter RC  Roseboom TJ  Bleker OP   Prenatal exposure to the Dutch famine and disease in later life: an overview Reprod Toxicol 2005 20 345 352 10.1016/j.reprotox.2005.04.005 15893910 
12. Roseboom TJ    Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview Twin Res 2001 4 293 298 10.1375/1369052012605 11869479 
13. Roseboom TJ    Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview Mol Cell Endocrinol 2001 185 93 98 10.1016/S0303-7207(01)00721-3 11738798 
14. St Clair D    Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961 JAMA 2005 294 557 562 10.1001/jama.294.5.557 16077049 
15. Avery OT  Macleod CM  McCarty M   Studies on the Chemical Nature of the Substance Inducing Transformation of Pneumococcal Types: Induction of Transformation by a Desoxyribonucleic Acid Fraction Isolated from Pneumococcus Type Iii J Exp Med 1944 79 137 158 10.1084/jem.79.2.137 19871359 
16. Hotchkiss RD   The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography J Biol Chem 1948 175 315 332 18873306 
17. Holliday R  Pugh JE   DNA modification mechanisms and gene activity during development Science 1975 187 226 232 10.1126/science.1111098 1111098 
18. Jarome TJ  Perez GA  Hauser RM  Hatch KM  Lubin FD   EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation J Neurosci 2018 38 7635 7648 10.1523/JNEUROSCI.0538-18.2018 30030400 
19. Lubin F. D.  Gupta S.  Parrish R. R.  Grissom N. M.  Davis R. L.   Epigenetic Mechanisms: Critical Contributors to Long-Term Memory Formation The Neuroscientist 2011 17 6 616 632 10.1177/1073858410386967 22130638 
20. Wang YJ    Histone acetylation in the olfactory bulb of young rats facilitates aversive olfactory learning and synaptic plasticity Neuroscience 2013 232 21 31 10.1016/j.neuroscience.2012.12.015 23262233 
21. Miller CA  Sweatt JD   Covalent modification of DNA regulates memory formation Neuron 2007 53 857 869 10.1016/j.neuron.2007.02.022 17359920 
22. Xie W    Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome Cell 2012 148 816 831 10.1016/j.cell.2011.12.035 22341451 
23. Hon GC    Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues Nat Genet 2013 45 1198 1206 10.1038/ng.2746 23995138 
24. Jang, H. S., Shin, W. J., Lee, J. E. & Do, J. T. CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function. Genes (Basel) 8, 10.3390/genes8060148 (2017).
25. Kozlenkov A    A unique role for DNA (hydroxy)methylation in epigenetic regulation of human inhibitory neurons Sci Adv 2018 4 eaau6190 10.1126/sciadv.aau6190 30263963 
26. Greer EL    DNA Methylation on N6-Adenine in C. elegans Cell 2015 161 868 878 10.1016/j.cell.2015.04.005 25936839 
27. Ji P  Wang X  Xie N  Li Y   N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate Stem cells international 2018 2018 3256524 3256524 10.1155/2018/3256524 30405719 
28. Stricker SH  Gotz M   DNA-Methylation: Master or Slave of Neural Fate Decisions? Front Neurosci 2018 12 5 10.3389/fnins.2018.00005 29449798 
29. Ratel D    Undetectable levels of N6-methyl adenine in mouse DNA: Cloning and analysis of PRED28, a gene coding for a putative mammalian DNA adenine methyltransferase FEBS Lett 2006 580 3179 3184 10.1016/j.febslet.2006.04.074 16684535 
30. Goto K    Expression of DNA methyltransferase gene in mature and immature neurons as well as proliferating cells in mice Differentiation 1994 56 39 44 10.1007/s002580050019 8026645 
31. Feng J  Chang H  Li E  Fan G   Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system J Neurosci Res 2005 79 734 746 10.1002/jnr.20404 15672446 
32. Morris MJ  Adachi M  Na ES  Monteggia LM   Selective role for DNMT3a in learning and memory Neurobiol Learn Mem 2014 115 30 37 10.1016/j.nlm.2014.06.005 24937014 
33. Feng J    Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons Nat Neurosci 2010 13 423 430 10.1038/nn.2514 20228804 
34. Welch JM    Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice Nature 2007 448 894 900 10.1038/nature06104 17713528 
35. Shmelkov Sergey V  Hormigo Adília  Jing Deqiang  Proenca Catia C  Bath Kevin G  Milde Till  Shmelkov Evgeny  Kushner Jared S  Baljevic Muhamed  Dincheva Iva  Murphy Andrew J  Valenzuela David M  Gale Nicholas W  Yancopoulos George D  Ninan Ipe  Lee Francis S  Rafii Shahin   Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice Nature Medicine 2010 16 5 598 602 10.1038/nm.2125 
36. Song M    Rare Synaptogenesis-Impairing Mutations in SLITRK5 Are Associated with Obsessive Compulsive Disorder PLoS One 2017 12 e0169994 10.1371/journal.pone.0169994 28085938 
37. Zuchner S    Multiple rare SAPAP3 missense variants in trichotillomania and OCD Mol Psychiatry 2009 14 6 9 10.1038/mp.2008.83 19096451 
38. Song M    Slitrk5 Mediates BDNF-Dependent TrkB Receptor Trafficking and Signaling Dev Cell 2015 33 690 702 10.1016/j.devcel.2015.04.009 26004511 
39. Pauls DL  Abramovitch A  Rauch SL  Geller DA   Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective Nat Rev Neurosci 2014 15 410 424 10.1038/nrn3746 24840803 
40. Catarina C et al. Direct functional innervation of dorsolateral striatum spiny projection neurons by the amygdala. Program No. 689.02/II9. 2017 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2017. Online. (2017).
41. Catarina C et al. Repeated activation of amygdala inputs to the dorsolateral striatum induces compulsive motor behavior. Session No. 147/6105. 2018 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2018. Online. (2018).
42. Genoux D    Protein phosphatase 1 is a molecular constraint on learning and memory Nature 2002 418 970 975 10.1038/nature00928 12198546 
43. Wendler E    The roles of the nucleus accumbens core, dorsomedial striatum, and dorsolateral striatum in learning: performance and extinction of Pavlovian fear-conditioned responses and instrumental avoidance responses Neurobiol Learn Mem 2014 109 27 36 10.1016/j.nlm.2013.11.009 24291572 
44. Candido EP  Reeves R  Davie JR   Sodium butyrate inhibits histone deacetylation in cultured cells Cell 1978 14 105 113 10.1016/0092-8674(78)90305-7 667927 
45. Kruh J   Effects of sodium butyrate, a new pharmacological agent, on cells in culture Mol Cell Biochem 1982 42 65 82 6174854 
46. Itzhak Y  Liddie S  Anderson KL   Sodium butyrate-induced histone acetylation strengthens the expression of cocaine-associated contextual memory Neurobiol Learn Mem 2013 102 34 42 10.1016/j.nlm.2013.03.007 23567105 
47. Jouvenceau A    Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus Eur J Neurosci 2006 24 564 572 10.1111/j.1460-9568.2006.04938.x 16903858 
48. Blitzer RD    Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP Science 1998 280 1940 1942 10.1126/science.280.5371.1940 9632393 
49. da Cruz e Silva EF    Differential expression of protein phosphatase 1 isoforms in mammalian brain J Neurosci 1995 15 3375 3389 10.1523/JNEUROSCI.15-05-03375.1995 7751917 
50. Alano A    Molecular characterization of a unique patient with epimerase-deficiency galactosaemia J Inherit Metab Dis 1998 21 341 350 10.1023/A:1005342306080 9700591 
51. Vecsey CG    Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation J Neurosci 2007 27 6128 6140 10.1523/JNEUROSCI.0296-07.2007 17553985 
52. Malvaez M  Wassum KM   Regulation of habit formation in the dorsal striatum Curr Opin Behav Sci 2018 20 67 74 10.1016/j.cobeha.2017.11.005 29713658 
53. McQuown SC    HDAC3 is a critical negative regulator of long-term memory formation J Neurosci 2011 31 764 774 10.1523/JNEUROSCI.5052-10.2011 21228185 
54. Broide RS    Distribution of histone deacetylases 1-11 in the rat brain J Mol Neurosci 2007 31 47 58 10.1007/BF02686117 17416969 
55. Alberts AS  Montminy M  Shenolikar S  Feramisco JR   Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts Mol Cell Biol 1994 14 4398 4407 10.1128/MCB.14.7.4398 7516466 
56. Gandolfi D    Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer Front Cell Neurosci 2017 11 184 10.3389/fncel.2017.00184 28701927 
57. Ortega-Martinez S   A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis Front Mol Neurosci 2015 8 46 10.3389/fnmol.2015.00046 26379491 
58. Woldemichael BT  Bohacek J  Gapp K  Mansuy IM   Epigenetics of memory and plasticity Prog Mol Biol Transl Sci 2014 122 305 340 10.1016/B978-0-12-420170-5.00011-8 24484706 
59. Gu T    DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells Genome Biol 2018 19 88 10.1186/s13059-018-1464-7 30001199 
60. Guo JU    Neuronal activity modifies the DNA methylation landscape in the adult brain Nat Neurosci 2011 14 1345 1351 10.1038/nn.2900 21874013 
61. Sheng M  Erturk A   Long-term depression: a cell biological view Philos Trans R Soc Lond B Biol Sci 2014 369 20130138 10.1098/rstb.2013.0138 24298141 
62. Luo R    A dopaminergic switch for fear to safety transitions Nat Commun 2018 9 2483 10.1038/s41467-018-04784-7 29950562 
63. Su D  Cha YM  West AE   Mutation of MeCP2 alters transcriptional regulation of select immediate-early genes Epigenetics 2012 7 146 154 10.4161/epi.7.2.18907 22395464 
64. Rangasamy S    Reduced neuronal size and mTOR pathway activity in the Mecp2 A140V Rett syndrome mouse model F1000Res 2016 5 2269 10.12688/f1000research.8156.1 27781091 
65. Chao HT  Zoghbi HY  Rosenmund C   MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number Neuron 2007 56 58 65 10.1016/j.neuron.2007.08.018 17920015 
66. Korb E  Finkbeiner S   Arc in synaptic plasticity: from gene to behavior Trends Neurosci 2011 34 591 598 10.1016/j.tins.2011.08.007 21963089 
67. Nikolaienko O  Patil S  Eriksen MS  Bramham CR   Arc protein: a flexible hub for synaptic plasticity and cognition Semin Cell Dev Biol 2018 77 33 42 10.1016/j.semcdb.2017.09.006 28890419 
68. Pastuzyn ED    The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer Cell 2018 173 275 10.1016/j.cell.2018.03.024 29570995 
69. Hebb, D. O. The organization of behavior; a neuropsychological theory. (Wiley, 1949).
70. Cheray M  Pacaud R  Nadaradjane A  Vallette FM  Cartron P-F   Specific inhibition of one DNMT1-including complex influences tumor initiation and progression Clinical epigenetics 2013 5 9 9 10.1186/1868-7083-5-9 23809695 
71. Mathilde C  Romain P  Eric H  Francois MV  Pierre-Francois C   DNMT Inhibitors in Cancer, Current Treatments and Future Promising Approach: Inhibition of Specific DNMT-Including Complexes Epigenetic Diagnosis & Therapy (Discontinued) 2015 1 37 48 10.2174/2214083201666150221002056 
72. Abe H    CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage Science 2018 360 50 10.1126/science.aao2300 29622647 
73. Calias P  Banks WA  Begley D  Scarpa M  Dickson P   Intrathecal delivery of protein therapeutics to the brain: a critical reassessment Pharmacol Ther 2014 144 114 122 10.1016/j.pharmthera.2014.05.009 24854599 
74. Doyle JP    Application of a translational profiling approach for the comparative analysis of CNS cell types Cell 2008 135 749 762 10.1016/j.cell.2008.10.029 19013282 
75. Ade KK  Wan Y  Chen M  Gloss B  Calakos N   An Improved BAC Transgenic Fluorescent Reporter Line for Sensitive and Specific Identification of Striatonigral Medium Spiny Neurons Front Syst Neurosci 2011 5 32 10.3389/fnsys.2011.00032 21713123 
76. Boyden ES  Zhang F  Bamberg E  Nagel G  Deisseroth K   Millisecond-timescale, genetically targeted optical control of neural activity Nat Neurosci 2005 8 1263 1268 10.1038/nn1525 16116447 
77. Ahmari SE    Repeated cortico-striatal stimulation generates persistent OCD-like behavior Science 2013 340 1234 1239 10.1126/science.1234733 23744948 
78. Lecorps B  Rodel HG  Feron C   Assessment of anxiety in open field and elevated plus maze using infrared thermography Physiol Behav 2016 157 209 216 10.1016/j.physbeh.2016.02.014 26884121 
79. Carola V  D’Olimpio F  Brunamonti E  Mangia F  Renzi P   Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice Behav Brain Res 2002 134 49 57 10.1016/S0166-4328(01)00452-1 12191791 
80. Jia Y  Gall CM  Lynch G   Presynaptic BDNF promotes postsynaptic long-term potentiation in the dorsal striatum J Neurosci 2010 30 14440 14445 10.1523/JNEUROSCI.3310-10.2010 20980601 
81. Kreitzer AC  Malenka RC   Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson’s disease models Nature 2007 445 643 647 10.1038/nature05506 17287809 
82. Rodriguez A  Ehlenberger DB  Dickstein DL  Hof PR  Wearne SL   Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images PLoS One 2008 3 e1997 10.1371/journal.pone.0001997 18431482

